Literature DB >> 28258205

The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy.

Ajay Kumar1, Harry T Chugani2.   

Abstract

Epilepsy is one of the most common yet diverse neurologic disorders, affecting almost 1%-2% of the population. Presently, radionuclide imaging such as PET and SPECT is not used in the primary diagnosis or evaluation of recent-onset epilepsy. However, it can play a unique and important role in certain specific situations, such as in noninvasive presurgical localization of epileptogenic brain regions in intractable-seizure patients being considered for epilepsy surgery. Radionuclide imaging can be particularly useful if MR imaging is either negative for lesions or shows several lesions of which only 1 or 2 are suspected to be epileptogenic and if electroencephalogram changes are equivocal or discordant with the structural imaging. Similarly, PET and SPECT can also be useful for evaluating the functional integrity of the rest of the brain and may provide useful information on the possible pathogenesis of the neurocognitive and behavioral abnormalities frequently observed in these patients.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG; PET; SPECT; epilepsy; epilepsy surgery; epilepsy syndromes; radionuclide

Mesh:

Substances:

Year:  2017        PMID: 28258205     DOI: 10.2967/jnumed.112.114397

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  8 in total

Review 1.  From simultaneous to synergistic MR-PET brain imaging: A review of hybrid MR-PET imaging methodologies.

Authors:  Zhaolin Chen; Sharna D Jamadar; Shenpeng Li; Francesco Sforazzini; Jakub Baran; Nicholas Ferris; Nadim Jon Shah; Gary F Egan
Journal:  Hum Brain Mapp       Date:  2018-08-04       Impact factor: 5.038

Review 2.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

Review 3.  Use of Innovative SPECT Techniques in the Presurgical Evaluation of Patients with Nonlesional Extratemporal Drug-Resistant Epilepsy.

Authors:  Ahmed Yassin; Khalid El-Salem; Abdel-Hameed Al-Mistarehi; Aiman Momani; Anas M Zein Alaabdin; Palak Shah; James Michael Mountz; Anto I Bagić
Journal:  Mol Imaging       Date:  2021-03-02       Impact factor: 4.488

Review 4.  Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology.

Authors:  Marion Bankstahl; Jens P Bankstahl
Journal:  Front Vet Sci       Date:  2017-12-13

Review 5.  PET and ictal SPECT can be helpful for localizing epileptic foci.

Authors:  Tim J von Oertzen
Journal:  Curr Opin Neurol       Date:  2018-04       Impact factor: 5.710

6.  PISCOM: a new procedure for epilepsy combining ictal SPECT and interictal PET.

Authors:  Andrés Perissinotti; Aida Niñerola-Baizán; Sebastià Rubí; Mar Carreño; Berta Marti-Fuster; Javier Aparicio; Maria Mayoral; Antonio Donaire; Nuria Sanchez-Izquierdo; Nuria Bargalló; Jordi Rumiá; Teresa Boget; Francesca Pons; Francisco Lomeña; Domènec Ros; Javier Pavía; Xavier Setoain
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-01       Impact factor: 9.236

7.  Clinical Usefulness of SISCOM-SPM Compared to Visual Analysis to Locate the Epileptogenic Zone.

Authors:  Carla Oliveira Young; Elba C S C Etchbehere; Edna Marina Souza; Sergio Querino Brunetto; Allan de Oliveira Santos; Mariana C L Lima; Sebastian Ortiz-De la Rosa; Marina Alvim; Clarissa Lin Yasuda; Celso Darío Ramos; Fernando Cendes; Barbara Juarez Amorim
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

8.  Evaluation of brain FDG PET images in temporal lobe epilepsy for lateralization of epileptogenic focus using data mining methods

Authors:  Ümit Özgür Akdemir; Irem Çapraz; Seda Gülbahar Ateş; Kerim Şeker; Uğuray Aydos; Gökhan Kurt; Neşe Karabacak; Lütfiye Özlem Atay; Erhan Bilir
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.